<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04117204</url>
  </required_header>
  <id_info>
    <org_study_id>018-095</org_study_id>
    <nct_id>NCT04117204</nct_id>
  </id_info>
  <brief_title>Cardiorenal Protective Diet</brief_title>
  <acronym>CPD</acronym>
  <official_title>Identifying a Cardiorenal Protective Diet in a Lower-income African American Population With Chronic Kidney Disease at Risk for Cardiovascular Disease.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baylor Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baylor Research Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate providing fruits and vegetables in a sustainable community care
      clinic setting, in addition to routine medical care, to individuals with CKD (Stage 2-4) on
      CKD and CVD risk, or cardio-renal risk factors. Further, metabolomics profiling will be used
      to study how change in the diet affects disease risk. Data from this study will be published
      in peer-reviewed journals, presented at national conferences, and will serve as pilot data to
      guide and strengthen applications for NIH funding.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes from baseline in fruit and vegetable intake at 6 weeks and 3 months.</measure>
    <time_frame>Baseline; 6 weeks and 3 months</time_frame>
    <description>Track changes in fruit and vegetable intake via ASA24 dietary recall food diary.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes from baseline in systolic and diastolic blood pressure at 6 weeks and 3 months.</measure>
    <time_frame>Baseline; 6 weeks and 3 months</time_frame>
    <description>Measure changes in systolic/diastolic blood pressure (mmHg) to assess cardiovascular disease (CVD) risk.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline of urine albumin-to-creatinine ration (ACR) at 6 weeks and 3 months.</measure>
    <time_frame>Baseline; 6 weeks and 3 months</time_frame>
    <description>Measure of renal damage.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Metabolomics will be used to profile how changes in diet effects disease risk.</measure>
    <time_frame>Baseline and 6 Weeks</time_frame>
    <description>Urine and plasma specimens will be collected for metabolomic analysis as novel biomarkers may appear in both sample types.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Chronic Kidney Diseases</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Fruits and Vegetables</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive a prescribed amount of free fruits and vegetables (F&amp;V) for 6 weeks of pick-up at a farm stand or direct delivery. After 6 weekly pick-up/deliveries, participants will be provided vouchers and reminders to obtain F&amp;V at farm stands for an additional 6 weeks with minimal contact.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wait List Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group will not receive a prescribed amount of free fruits and vegetables (F&amp;V) for 12 weeks. They will serve as the control group. After 12 weeks of control and data comparisons, they will be given 12 weeks of vouchers with minimal contact.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fruits and Vegetables</intervention_name>
    <description>Fruits and Vegetable delivery, once a week for 12 weeks.</description>
    <arm_group_label>Fruits and Vegetables</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Willingness to participate in a 3-month F&amp;V study.

          -  Positive urine dipstick (Proteinuria and/or Albumin-to-Creatinine Ratio &gt;=10).

          -  African-American (self-declared) race

          -  A current diagnosis of hypertension or a current blood pressure reading consistent
             with hypertension (SBP &gt;= 140 and/or DBP &gt;=90).

          -  Access to the internet via personal computer or mobile device.

          -  Ability to read and write in English.

        Exclusion Criteria:

          -  Negative urine dipstick.

          -  Currently receiving dialysis or needing dialysis (Stage 5 Kidney Disease)

          -  Have received or need a kidney transplant.

          -  Pregnant or planning to become pregnant in the next 6 months.

          -  Baseline urine potassium &gt; 60mEq/g creatinine

          -  Negative diagnosis of hypertension or blood pressure reading (SBP &lt;140 or DBP &lt;90).

          -  Nephrotic proteinuria demonstrated on urine ACR measurement.

          -  Lacking access to the internet via personal computer or mobile device.

          -  Unable to read or write in English.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heather Kitzman, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor Scott &amp; White Health and Wellness Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Heather Kitzman, PhD</last_name>
    <phone>214-865-3082</phone>
    <email>Heather.KitzmanCarmichael@BSWHealth.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Brian Vilayvanh, BSN, RN</last_name>
    <phone>214-865-3071</phone>
    <email>Brian.Vilayvanh@BSWHealth.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Baylor Scott &amp; White Health and Wellness Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brian Vilayvanh, BSN, RN</last_name>
      <phone>214-865-3071</phone>
      <email>Brian.Vilayvanh@BSWHealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Patricia Allison, CHW</last_name>
      <phone>214-865-3053</phone>
      <email>Patricia.Allison@BSWHealth.org</email>
    </contact_backup>
    <investigator>
      <last_name>Heather Kitzman, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Donald Wesson, MD, MBA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Mendu ML, Erickson KF, Hostetter TH, Winkelmayer WC, Olan G, Meyer RN, Hakim R, Sedor JR. Federal Funding for Kidney Disease Research: A Missed Opportunity. Am J Public Health. 2016 Mar;106(3):406-7. doi: 10.2105/AJPH.2015.303009.</citation>
    <PMID>26885959</PMID>
  </reference>
  <reference>
    <citation>Saran R, Li Y, Robinson B, Abbott KC, Agodoa LY, Ayanian J, Bragg-Gresham J, Balkrishnan R, Chen JL, Cope E, Eggers PW, Gillen D, Gipson D, Hailpern SM, Hall YN, He K, Herman W, Heung M, Hirth RA, Hutton D, Jacobsen SJ, Kalantar-Zadeh K, Kovesdy CP, Lu Y, Molnar MZ, Morgenstern H, Nallamothu B, Nguyen DV, O'Hare AM, Plattner B, Pisoni R, Port FK, Rao P, Rhee CM, Sakhuja A, Schaubel DE, Selewski DT, Shahinian V, Sim JJ, Song P, Streja E, Kurella Tamura M, Tentori F, White S, Woodside K, Hirth RA. US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2016 Mar;67(3 Suppl 1):Svii, S1-305. doi: 10.1053/j.ajkd.2015.12.014. Review.</citation>
    <PMID>26925525</PMID>
  </reference>
  <reference>
    <citation>Gargiulo R, Suhail F, Lerma EV. Cardiovascular disease and chronic kidney disease. Dis Mon. 2015 Sep;61(9):403-13. doi: 10.1016/j.disamonth.2015.07.005. Epub 2015 Aug 29. Review.</citation>
    <PMID>26328516</PMID>
  </reference>
  <reference>
    <citation>Banks J, Marmot M, Oldfield Z, Smith JP. Disease and disadvantage in the United States and in England. JAMA. 2006 May 3;295(17):2037-45.</citation>
    <PMID>16670412</PMID>
  </reference>
  <reference>
    <citation>So BH, Methven S, Hair MD, Jardine AG, MacGregor MS. Socio-economic status influences chronic kidney disease prevalence in primary care: a community-based cross-sectional analysis. Nephrol Dial Transplant. 2015 Jun;30(6):1010-7. doi: 10.1093/ndt/gfu408. Epub 2015 Jan 13.</citation>
    <PMID>25586406</PMID>
  </reference>
  <reference>
    <citation>Vart P, Gansevoort RT, Coresh J, Reijneveld SA, Bültmann U. Socioeconomic measures and CKD in the United States and The Netherlands. Clin J Am Soc Nephrol. 2013 Oct;8(10):1685-93. doi: 10.2215/CJN.12521212. Epub 2013 Jun 27.</citation>
    <PMID>23813554</PMID>
  </reference>
  <reference>
    <citation>Peralta CA, Vittinghoff E, Bansal N, Jacobs D Jr, Muntner P, Kestenbaum B, Lewis C, Siscovick D, Kramer H, Shlipak M, Bibbins-Domingo K. Trajectories of kidney function decline in young black and white adults with preserved GFR: results from the Coronary Artery Risk Development in Young Adults (CARDIA) study. Am J Kidney Dis. 2013 Aug;62(2):261-6. doi: 10.1053/j.ajkd.2013.01.012. Epub 2013 Mar 7.</citation>
    <PMID>23473985</PMID>
  </reference>
  <reference>
    <citation>Goraya N, Simoni J, Jo C, Wesson DE. Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy. Kidney Int. 2012 Jan;81(1):86-93. doi: 10.1038/ki.2011.313. Epub 2011 Aug 31.</citation>
    <PMID>21881553</PMID>
  </reference>
  <reference>
    <citation>Goraya N, Simoni J, Jo CH, Wesson DE. A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate. Clin J Am Soc Nephrol. 2013 Mar;8(3):371-81. doi: 10.2215/CJN.02430312. Epub 2013 Feb 7.</citation>
    <PMID>23393104</PMID>
  </reference>
  <reference>
    <citation>Goraya N, Simoni J, Jo CH, Wesson DE. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate. Kidney Int. 2014 Nov;86(5):1031-8. doi: 10.1038/ki.2014.83. Epub 2014 Apr 2.</citation>
    <PMID>24694986</PMID>
  </reference>
  <reference>
    <citation>Young BA, Katz R, Boulware LE, Kestenbaum B, de Boer IH, Wang W, Fülöp T, Bansal N, Robinson-Cohen C, Griswold M, Powe NR, Himmelfarb J, Correa A. Risk Factors for Rapid Kidney Function Decline Among African Americans: The Jackson Heart Study (JHS). Am J Kidney Dis. 2016 Aug;68(2):229-239. doi: 10.1053/j.ajkd.2016.02.046. Epub 2016 Apr 9.</citation>
    <PMID>27066930</PMID>
  </reference>
  <reference>
    <citation>Boeing H, Bechthold A, Bub A, Ellinger S, Haller D, Kroke A, Leschik-Bonnet E, Müller MJ, Oberritter H, Schulze M, Stehle P, Watzl B. Critical review: vegetables and fruit in the prevention of chronic diseases. Eur J Nutr. 2012 Sep;51(6):637-63. doi: 10.1007/s00394-012-0380-y. Epub 2012 Jun 9. Review.</citation>
    <PMID>22684631</PMID>
  </reference>
  <reference>
    <citation>Rehm CD, Peñalvo JL, Afshin A, Mozaffarian D. Dietary Intake Among US Adults, 1999-2012. JAMA. 2016 Jun 21;315(23):2542-53. doi: 10.1001/jama.2016.7491.</citation>
    <PMID>27327801</PMID>
  </reference>
  <reference>
    <citation>Newgard CB. Metabolomics and Metabolic Diseases: Where Do We Stand? Cell Metab. 2017 Jan 10;25(1):43-56. doi: 10.1016/j.cmet.2016.09.018. Epub 2016 Oct 27. Review.</citation>
    <PMID>28094011</PMID>
  </reference>
  <reference>
    <citation>Ganna A, Salihovic S, Sundström J, Broeckling CD, Hedman AK, Magnusson PK, Pedersen NL, Larsson A, Siegbahn A, Zilmer M, Prenni J, Arnlöv J, Lind L, Fall T, Ingelsson E. Large-scale metabolomic profiling identifies novel biomarkers for incident coronary heart disease. PLoS Genet. 2014 Dec 11;10(12):e1004801. doi: 10.1371/journal.pgen.1004801. eCollection 2014 Dec.</citation>
    <PMID>25502724</PMID>
  </reference>
  <reference>
    <citation>Leaf DE, Jacob KA, Srivastava A, Chen ME, Christov M, Jüppner H, Sabbisetti VS, Martin A, Wolf M, Waikar SS. Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness. J Am Soc Nephrol. 2017 Jun;28(6):1877-1885. doi: 10.1681/ASN.2016080836. Epub 2016 Dec 27.</citation>
    <PMID>28028134</PMID>
  </reference>
  <reference>
    <citation>Xue C, Yang B, Zhou C, Dai B, Liu Y, Mao Z, Yu S, Mei C. Fibroblast Growth Factor 23 Predicts All-Cause Mortality in a Dose-Response Fashion in Pre-Dialysis Patients with Chronic Kidney Disease. Am J Nephrol. 2017;45(2):149-159. doi: 10.1159/000454959. Epub 2016 Dec 23. Review.</citation>
    <PMID>28006765</PMID>
  </reference>
  <reference>
    <citation>Rescigno T, Micolucci L, Tecce MF, Capasso A. Bioactive Nutrients and Nutrigenomics in Age-Related Diseases. Molecules. 2017 Jan 8;22(1). pii: E105. doi: 10.3390/molecules22010105. Review.</citation>
    <PMID>28075340</PMID>
  </reference>
  <reference>
    <citation>Wilson DK, Kitzman-Ulrich H, Resnicow K, Van Horn ML, St George SM, Siceloff ER, Alia KA, McDaniel T, Heatley V, Huffman L, Coulon S, Prinz R. An overview of the Families Improving Together (FIT) for weight loss randomized controlled trial in African American families. Contemp Clin Trials. 2015 May;42:145-57. doi: 10.1016/j.cct.2015.03.009. Epub 2015 Mar 30.</citation>
    <PMID>25835731</PMID>
  </reference>
  <reference>
    <citation>Wilson DK, Kitzman-Ulrich H, Williams JE, Saunders R, Griffin S, Pate R, Van Horn ML, Evans A, Hutto B, Addy CL, Mixon G, Sisson SB. An overview of &quot;The Active by Choice Today&quot; (ACT) trial for increasing physical activity. Contemp Clin Trials. 2008 Jan;29(1):21-31. Epub 2007 Jul 17.</citation>
    <PMID>17716952</PMID>
  </reference>
  <reference>
    <citation>Wilson DK, Trumpeter NN, St George SM, Coulon SM, Griffin S, Lee Van Horn M, Lawman HG, Wandersman A, Egan B, Forthofer M, Goodlett BD, Kitzman-Ulrich H, Gadson B. An overview of the &quot;Positive Action for Today's Health&quot; (PATH) trial for increasing walking in low income, ethnic minority communities. Contemp Clin Trials. 2010 Nov;31(6):624-33. doi: 10.1016/j.cct.2010.08.009. Epub 2010 Aug 27.</citation>
    <PMID>20801233</PMID>
  </reference>
  <reference>
    <citation>Kitzman H, Dodgen L, Mamun A, Slater JL, King G, Slater D, King A, Mandapati S, DeHaven M. Community-based participatory research to design a faith-enhanced diabetes prevention program: The Better Me Within randomized trial. Contemp Clin Trials. 2017 Nov;62:77-90. doi: 10.1016/j.cct.2017.08.003. Epub 2017 Aug 12.</citation>
    <PMID>28807739</PMID>
  </reference>
  <reference>
    <citation>Armstrong C; Joint National Committee. JNC8 guidelines for the management of hypertension in adults. Am Fam Physician. 2014 Oct 1;90(7):503-4.</citation>
    <PMID>25369633</PMID>
  </reference>
  <reference>
    <citation>Scialla JJ, Parekh RS, Eustace JA, Astor BC, Plantinga L, Jaar BG, Shafi T, Coresh J, Powe NR, Melamed ML. Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis. Am J Nephrol. 2015;42(1):25-34. doi: 10.1159/000438999. Epub 2015 Aug 20.</citation>
    <PMID>26287973</PMID>
  </reference>
  <reference>
    <citation>Gutiérrez OM, Rostand SG. Chronic kidney disease in African Americans: past, present, and future: introduction. Semin Nephrol. 2013 Sep;33(5):407-8. doi: 10.1016/j.semnephrol.2013.07.001.</citation>
    <PMID>24119845</PMID>
  </reference>
  <reference>
    <citation>Gutiérrez OM, Parsa A, Isakova T, Scialla JJ, Chen J, Flack JM, Nessel LC, Gupta J, Bellovich KA, Steigerwalt S, Sondheimer JH, Wright JT Jr, Feldman HI, Kusek JW, Lash JP, Wolf M. Genetic African Ancestry and Markers of Mineral Metabolism in CKD. Clin J Am Soc Nephrol. 2016 Apr 7;11(4):653-62. doi: 10.2215/CJN.08020715. Epub 2016 Feb 8.</citation>
    <PMID>26912553</PMID>
  </reference>
  <reference>
    <citation>Gutiérrez OM, Judd SE, Irvin MR, Zhi D, Limdi N, Palmer ND, Rich SS, Sale MM, Freedman BI. APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans. Nephrol Dial Transplant. 2016 Apr;31(4):602-8. doi: 10.1093/ndt/gfv229. Epub 2015 Jul 6.</citation>
    <PMID>26152403</PMID>
  </reference>
  <reference>
    <citation>Saneei P, Salehi-Abargouei A, Esmaillzadeh A, Azadbakht L. Influence of Dietary Approaches to Stop Hypertension (DASH) diet on blood pressure: a systematic review and meta-analysis on randomized controlled trials. Nutr Metab Cardiovasc Dis. 2014 Dec;24(12):1253-61. doi: 10.1016/j.numecd.2014.06.008. Epub 2014 Jun 27. Review.</citation>
    <PMID>25149893</PMID>
  </reference>
  <reference>
    <citation>Breier M, Wahl S, Prehn C, Fugmann M, Ferrari U, Weise M, Banning F, Seissler J, Grallert H, Adamski J, Lechner A. Targeted metabolomics identifies reliable and stable metabolites in human serum and plasma samples. PLoS One. 2014 Feb 24;9(2):e89728. doi: 10.1371/journal.pone.0089728. eCollection 2014.</citation>
    <PMID>24586991</PMID>
  </reference>
  <reference>
    <citation>Carayol M, Licaj I, Achaintre D, Sacerdote C, Vineis P, Key TJ, Onland Moret NC, Scalbert A, Rinaldi S, Ferrari P. Reliability of Serum Metabolites over a Two-Year Period: A Targeted Metabolomic Approach in Fasting and Non-Fasting Samples from EPIC. PLoS One. 2015 Aug 14;10(8):e0135437. doi: 10.1371/journal.pone.0135437. eCollection 2015.</citation>
    <PMID>26274920</PMID>
  </reference>
  <reference>
    <citation>Nkuipou-Kenfack E, Duranton F, Gayrard N, Argilés À, Lundin U, Weinberger KM, Dakna M, Delles C, Mullen W, Husi H, Klein J, Koeck T, Zürbig P, Mischak H. Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease. PLoS One. 2014 May 9;9(5):e96955. doi: 10.1371/journal.pone.0096955. eCollection 2014.</citation>
    <PMID>24817014</PMID>
  </reference>
  <reference>
    <citation>Dallmann G, Klavins K, Koal T. Targeted Quantitative Metabolomics Using Dried Plasma Spot Cards. https:novilytic.com/wp-content/uploads/2015/01/Metabolomics-with-Noviplex-Cards.pdf</citation>
  </reference>
  <reference>
    <citation>Hong DS, Oh IH, Park JS, Lee CH, Kang CM, Kim GH. Evaluation of Urinary Indices for Albuminuria and Proteinuria in Patients with Chronic Kidney Disease. Kidney Blood Press Res. 2016;41(3):258-66. doi: 10.1159/000443429. Epub 2016 Apr 29.</citation>
    <PMID>27160690</PMID>
  </reference>
  <reference>
    <citation>Thompson FE, Dixit-Joshi S, Potischman N, Dodd KW, Kirkpatrick SI, Kushi LH, Alexander GL, Coleman LA, Zimmerman TP, Sundaram ME, Clancy HA, Groesbeck M, Douglass D, George SM, Schap TE, Subar AF. Comparison of Interviewer-Administered and Automated Self-Administered 24-Hour Dietary Recalls in 3 Diverse Integrated Health Systems. Am J Epidemiol. 2015 Jun 15;181(12):970-8. doi: 10.1093/aje/kwu467. Epub 2015 May 10.</citation>
    <PMID>25964261</PMID>
  </reference>
  <reference>
    <citation>Institute Nc. ASA24 Automated Self-Administered 24-Hour Dietary Assessment Tool. http://epi.grants.cancer.gov/asa24/</citation>
  </reference>
  <reference>
    <citation>Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic Evaluation in Clinical Trials. Oxford: Oxford University Press; 2007.</citation>
  </reference>
  <reference>
    <citation>Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996 Oct 9;276(14):1172-7. Review.</citation>
    <PMID>8827972</PMID>
  </reference>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>October 3, 2019</study_first_submitted>
  <study_first_submitted_qc>October 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 7, 2019</study_first_posted>
  <last_update_submitted>October 3, 2019</last_update_submitted>
  <last_update_submitted_qc>October 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CVD</keyword>
  <keyword>Dietary Intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

